Shockwave Receives FDA Breakthrough Device Designation for the Investigational Coronary IVL System
IVL-Facilitated Transfemoral TAVR
Study Now Published
MINIMIZE TRAUMA – Minimize trauma to soft tissue by safely selecting and fracturing intimal and medial calcium
OPTIMIZE OUTCOMES – Optimize outcomes while reducing complications and cost escalation
SIMPLIFY PROCEDURES – Simple and intuitive system that makes complex calcified procedures more predictable
The First Applications of
Learn more about the potential of IVL in patients with aortic stenosis (AS) or IVL as a means to facilitate transfemoral access and avoid alternative routes by clicking on one of the below:
Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.
Mark your calendar to hear @Dr_Bisdas present his unique perspective of the value of #IVL at the #ShockwaveIVL Boot… https://t.co/AQKMvrNMIq
Watch a calcified left #iliac successfully treated with #IVL to facilitate #Impella delivery in this video with Dr.… https://t.co/ibmgVZL3lQ
In addition to the presentations at our #LINC2020 booth, we have three #ShockwaveIVL focused sessions in the Main A… https://t.co/dhec8uo0EA
We are honored to have so many esteemed physicians in our #ShockwaveIVL Booth Speaker Series at #LINC2020! See the… https://t.co/enGBzCKLak
Everyone loves a new #Rotatripsy publication! Learn about #IntravascularLithotripsy for the treatment of un-dilatab… https://t.co/QJqlAGVO5W
First #ShockwaveIVL cases in Saudi Arabia last week! Congrats to Dr @mirvatalasnag at King Fahad Armed Hospital in… https://t.co/a0UYCKqpQX
Well said, Dr. Bella Huasen, and thank you for sharing!
https://t.co/8FyBbbukl1
We are excited to announce the lineup for our very first ever #ShockwaveIVL Booth Speaker Series at #LINC2020! Chec… https://t.co/wi5ZSYXud9
We had our first #ShockwaveIVL case in India streamed live at CHIP CTO INDIA 2020! Watch the coronary #IVL procedur… https://t.co/2Z5XmZa8dy
First #ShockwaveIVL cases in India! Congratulations to operators Drs Ashok Seth, @DrJMHill & @drvrastogi at Fortis… https://t.co/KOi16AiXj1
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.
